Investigator

Lauren G. Banaszak

Clinical Instructor · Memorial Sloan Kettering Cancer Center, Leukemia

Research Interests

LGBLauren G. Banaszak
Papers(1)
Age-Related Germline …
Collaborators(10)
Maria CarloMichael F. BergerQin ZhouSarah KaneVicky MakkerYelena KemelYing L. LiuYonina R. Murciano-Go…Zsofia K. StadlerAlexia Iasonos
Institutions(2)
Memorial Sloan Ketter…Memorial Sloan Ketter…

Papers

Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases

PURPOSE Early-onset endometrial cancer (eoEC) is increasing, and germline drivers may be enriched in younger patients. We sought to define germline pathogenic variants (gPVs) in those with EC by age. METHODS We identified patients with EC who underwent clinical tumor-normal sequencing from December 2014 to June 2021 and collected clinical variables. Logistic regression models evaluated associations between age at EC diagnosis and presence of gPV, biallelic inactivation, and Lynch Syndrome (LS). Age categories were defined as early-onset (eoEC, EC < 50 years) and late-onset (EC ≥ 70 years) and were compared with those diagnosed ages 50-69 years. RESULTS Among 1,625 patients with EC, the median age at diagnosis was 63 (range, 24-96) years. We observed gPV in 28 (16%) of 170 patients with eoEC, 152 (14%) of 1,066 patients diagnosed age 50-69 years, and 36 (9%) of 389 patients with late-onset EC ( P = .016). LS was enriched in eoEC, with 6.5% of patients diagnosed age <50 years having LS. In multivariable models compared with those with EC diagnosed age 50-69 years, eoEC was more likely to exhibit biallelic inactivation (odds ratio, 3.34 [95% CI, 1.44 to 7.35]) and be associated with LS (hazard ratio [HR], 3.49 [95% CI, 1.63 to 7.01]). Among early-onset EC, 14 (50%) of 28 gPV were high penetrance and 14 (50%) of 28 exhibited biallelic inactivation. However, heterogeneity was observed, and rates of gPV were 8.9% and 19%, biallelic inactivation was 0% and 11%, and LS was 2.2% and 8% in those diagnosed age <40 years and 40-49 years, respectively. CONCLUSION Rates of gPV, biallelic inactivation, and LS differ across age groups for EC, with high-penetrant genes driving tumorigenesis enriched in younger patients. However, very-early-onset EC may have different drivers and necessitates more research.

16Works
1Papers
16Collaborators
Myelodysplastic SyndromesEndometrial NeoplasmsNeoplasmsGenetic Predisposition to Disease

Positions

2024–

Clinical Instructor

Memorial Sloan Kettering Cancer Center · Leukemia

Education

2024

Internal Medicine Residency, Hematology/Medical Oncology Fellowship

University of Wisconsin-Madison · Medicine

2017

Doctor of Medicine

Cleveland Clinic Lerner College of Medicine

2012

Bachelors of Science, Molecular Biology

University of Wisconsin-Madison

Country

US